Selected article for: "art state and single cell"

Author: Seow, Justine Jia Wen; Wong, Regina Men Men; Pai, Rhea; Sharma, Ankur
Title: Single‐Cell RNA Sequencing for Precision Oncology: Current State-of-Art
  • Cord-id: z2erqkr9
  • Document date: 2020_6_2
  • ID: z2erqkr9
    Snippet: Tumors exhibit genetic and phenotypic diversity leading to intra-tumor heterogeneity (ITH). Further complex ecosystem (stromal and immune cells) of tumors contributes into the ITH. This ITH allows tumors to overcome various selection pressures such as anti-cancer therapies and metastasis at distant organs. Single-cell RNA-seq (scRNA-seq) has provided unprecedented insights into ITH and its implications in drug resistance and metastasis. As scRNA-seq technology grows and provides many new finding
    Document: Tumors exhibit genetic and phenotypic diversity leading to intra-tumor heterogeneity (ITH). Further complex ecosystem (stromal and immune cells) of tumors contributes into the ITH. This ITH allows tumors to overcome various selection pressures such as anti-cancer therapies and metastasis at distant organs. Single-cell RNA-seq (scRNA-seq) has provided unprecedented insights into ITH and its implications in drug resistance and metastasis. As scRNA-seq technology grows and provides many new findings, new tools on different programming platforms are frequently generated. Here, we aim to provide a framework and guidelines for new entrants into the field of scRNA-seq. In this review, we discuss the current state-of-art of scRNA-seq analysis step-by-step including filtering, normalization and analysis. First, we discuss the brief history of experimental methods, followed by data processing and implications in precision oncology.

    Search related documents:
    Co phrase search for related documents
    • additional evidence and low number: 1
    • additional evidence and low quality: 1, 2, 3, 4, 5, 6
    • additional evidence and machine learning: 1, 2
    • additional information and liver cancer: 1, 2
    • additional information and low number: 1, 2, 3, 4, 5, 6
    • additional information and low quality: 1, 2, 3, 4, 5, 6, 7
    • additional information and machine learning: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • liver cancer and low quality: 1, 2
    • liver cancer and machine learning: 1
    • low number and machine learning: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • low quality and machine learning: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12